FernandoMSSimpsonJEMatthewsFBrayneCLewisCEBarberRet al
To view or add a comment, sign in FDA Approval Update The FDA has approved Sarclisa Escena (isatuximab-irfc) from Sanofi as a subcutaneous formulation of isatuximab for approved multiple myeloma treatment combinations
Whether you are dealing with rheumatoid arthritis (RA), psoriatic arthritis (PsA), lupus (SLE), Sjgrens disease (SD), or even osteoarthritis (OA), chronic inflammation keeps the immune system in a constant attack mode, leading to: Pain Swelling Stiffness Mobility problems Tissue and cartilage damage This chronic, ongoing inflammation not only makes joints hurt more, but it will worsen blood sugar control, fatigue, brain fog, and increase the risk of heart disease
Clinical Principle It is important to establish baseline values in order to evaluate later treatment responses